Paladin Labs Inc PLDLF

RE:RE:News...Sold For $77 a share with subsequent upside!!!!!!!!!!

[Barruch]

At $77 we would be selling far too cheaply!!!!!!

in my opinion.

With a closing price of $63.91 considering the growh rate, a 20% premium to yesterday's price is obviously in my opinion underpriced by PLB management.

From the press release "At $77.00 (CAD) per Paladin Labs share, the transaction represents a 20% premium to Paladin Labs' share price of $63.91 as of November 4, 2013,"

From PLB's website

Investment Highlights Strong revenue growth • 5 year Compounded Annual Growth Rate of 24% Healthy, robust business • Generated 67.6 million of EBITDA in 2011 or $3.27 per fully diluted share Rich, near-term pipeline for growth • 1 product awaiting regulatory approval • 3 products pending regulatory submission • 17 products in phase I, II and III

Not to mention a 52 week hi of $66.76.

Did management mention that $77 is only a 15.33% premium to the 52 week hi which I believe occurred as recently as early October. 2013

At a stated annual 5 year compounded growth rate of 24% this "offer" is ridiculously low and in my opinion irresponsible of management to accept such an offer.

 Hopefully a large or several activist shareholders will step forward and voice their dissappointment, concerns, and/or disapproval of this offer.

One thing that is noteably absent from the press release is what management's compensation will be under Endo Health Solutions
From today's press release"
Paladin will continue to be led by Paladin Labs' current management, will maintain its Montreal headquarters, and will operate in Canada under its current name, Paladin Labs Inc. "


Also from today's press release""It takes about 17 years of tough, hard work by many talented people to become an overnight success. We're proud that we were able to record 17 years of consecutive record revenues which drove a 51 times increase in Paladin's share price since our founding," said Jonathan Ross Goodman, Chairman of Paladin.


Why not continue with that same track record.

Comparing  ENDP's stock chart to PLB'S I'd rather continue to own PLB.

Also comparing ENDP'S financial report to PLB's I'd much rather own PLB.

I  will not be tendering my shares or those of which I have control over.

signed
one ticked off Barruch